139870 <common-name>Revumenib</common-name> <description>Revumenib is an organic compound with the chemical formula C32H47FN6O4S. Revumenib belongs to the benzoic acids and derivatives, a subclass of benzene and substituted derivatives within the organic compounds. With an average molecular weight of 630.82 g/mol, Revumenib is a heavy molecule. In terms of its pharmacological activity, the compound is recorded as an inhibitor of the protein target Menin (MEN1).</description> <cas>2169919-21-3</cas> <pubchem-id nil="true"/> <chemical-formula>C32H47FN6O4S</chemical-formula> <weight nil="true"/> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-04-14T22:16:02Z</created-at> <updated-at type="dateTime">2026-05-14T20:08:35Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id>DB18515</drugbank-id> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCN(C(C)C)C(=O)C1=CC(F)=CC=C1OC1=CN=CN=C1N1CC2(C1)CCN(C[C@H]1CC[C@@H](CC1)NS(=O)(=O)CC)CC2</moldb-smiles> <moldb-formula>C32H47FN6O4S</moldb-formula> <moldb-inchi>InChI=1S/C32H47FN6O4S/c1-5-39(23(3)4)31(40)27-17-25(33)9-12-28(27)43-29-18-34-22-35-30(29)38-20-32(21-38)13-15-37(16-14-32)19-24-7-10-26(11-8-24)36-44(41,42)6-2/h9,12,17-18,22-24,26,36H,5-8,10-11,13-16,19-21H2,1-4H3/t24-,26-</moldb-inchi> <moldb-inchikey>FRVSRBKUQZKTOW-YOCNBXQISA-N</moldb-inchikey> <moldb-average-mass type="decimal">630.82</moldb-average-mass> <moldb-mono-mass type="decimal">630.336353354</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>3.37</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM135763</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-ethyl-5-fluoro-N-(propan-2-yl)-2-{[4-(7-{[(1r,4r)-4-ethanesulfonamidocyclohexyl]methyl}-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl]oxy}benzamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Benzene and substituted derivatives</klass> <subklass>Benzoic acids and derivatives</subklass> <paper-count type="integer">533</paper-count> <sync-id>CED0010816</sync-id> <structure-inchikey>FRVSRBKUQZKTOW-YOCNBXQISA-N</structure-inchikey> <structure-fingerprint>404020040000000000008002000000002000040000c0000010000280000000002000001002020000000000020000002000000100000000400000000000600000000000002000000000000020000000000020000000000130000000000000000000000020010000000100002000104000000900020900000000000000000000100000000048000000000000000000000080200000000000008400000000000000800000000004000000000040080000002000000000080000488100000000000100000000000020009000400220000000030000000000000010004200000000010000410000000000040040000000000400800000000020000100000000040000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAsAAAAMAAAAIABBgBgAAAAAQMGAGAAAAAC AgcAKAAAAAMDBgBgAAAAAwEGAGAAAAABAwYAYAAAAAEDBgAoAAAAAwQIACgA AAADAgZAKAAAAAMEBkBoAAAAAwMBBkAoAAAAAwQJACAAAAABBkBoAAAAAwMB BkBoAAAAAwMBBkAoAAAAAwQIACgAAAADAgZAKAAAAAMEBkBoAAAAAwMBB0Ao AAAAAwMGQGgAAAADAwEHQCgAAAADAwZAKAAAAAMEBwAoAAAAAwMGAGAAAAAC AgYAIAAAAAQGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIHACAAAAADBgBgAAAA AgIGIDQAAAABAQQGAGAAAAACAgYAYAAAAAICBiA0AAAAAQEEBgBgAAAAAgIG AGAAAAACAgcAYAAAAAIBEAAgAAAABggAKAAAAAMCCAAoAAAAAwIGAGAAAAAC AgYAYAAAAAEDBgBgAAAAAgIGAGAAAAACAgsAAQABAgACAwADBAADBQACBiAG BygCBgggCAloDAkKaAwKCwAKDGgMDA1oDA0OaAwODyAPECAQEWgMERJoDBIT aAwTFGgMFBVoDBUWIBYXABcYABgZABgaABobABscABwdAB0eAB4fAB8gACAh ACEiACIjACEkACQlACUmCAIlJwgCJSgAKCkAHCoAKisADghoDBUQaAwZFgAj HgArGABCBQAAAAYIDg0MCgkGERITFBUQBBcYGRYGGhscKisYBh8gISIjHhcE AAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T04:51:06Z</structure-indexed-at> </compound>